Alison Huang, MD, MAS
@AlisonHuangMD
Followers
537
Following
3K
Media
58
Statuses
263
Physician scientist focused on aging, genitourinary health, and women’s health @UCSFDGIM @UCSFUrology @UCSF_Epibiostat (opinions are my own)
Joined May 2021
Glad to be enrolling older women in our TReatment of Incontinence for Underlying Physical and Mental Health (TRIUMPH) trial—it’s time to study medication effects beyond the bladder:
4
2
17
Neither panacea nor poison: the swinging pendulum of menopausal hormone therapy
Viewpoint: Menopause care should extend beyond hormone therapy, emphasizing individualized care, clinician training, and evidence-based management. https://t.co/L2vaKY6xyu
0
0
0
Few medications have captured the imagination—and provoked such ire—as menopausal hormone therapy. For decades, MHT has served as a lightning rod for medical and cultural debate about management of menopause, aging, and women’s health. https://t.co/2ok9l9tedE
0
0
1
Impressive results from the PRACTICAL trial led by @alaynemarkland in @JAMANetworkOpen: a mobile health intervention produced earlier and greater improvement in urinary incontinence than a clinician-based approach involving limited telehealth care: https://t.co/QgVzArO6AY
jamanetwork.com
This randomized clinical trial compares the effectiveness of urinary incontinence behavioral treatments delivered via a mobile health app vs a video visit and assesses the effect of a booster video...
0
0
0
Clinicians can enhance patient understanding by using numerical data instead of verbal probabilities, consistent denominators, absolute risk comparisons, and clear context for unfamiliar data types. https://t.co/dcOmkNwtlS
8
237
668
Yes—appreciate their courage. Dissent, thoughtfully expressed, is critical to both scientific inquiry and a functioning society.
0
0
1
Our @UCSFDGIM @UCSF_DOCIT faculty investigator @LisaRotenstein sharing her findings about understaffed physician teams with colleagues and journals at #SGIM25:
Editorial: At #SGIM25, JAMA Internal Medicine featured studies on physician well-being, health equity, and end-of-life care practices. https://t.co/29rid3kYli
@pdfriedmann
0
1
7
Glad to discuss the evidence for efficacy and safety of newer non-hormonal treatments for hot flashes with @lindseybever at @washingtonpost, who highlights the need for affordable and well-tolerated options for women with debilitating symptoms: https://t.co/z6NkzdZulV
Estrogen therapy remains the most effective treatment for menopausal vasomotor symptoms, but our @JAMAInternalMed insights article describes evidence-based non-hormonal treatment options for women who are not candidates for or wish to avoid hormones: https://t.co/GYMWDuog9W
0
2
2
Hot flashes can be emotionally distressing for midlife women—but will treating hot flashes improve mood? Clinicians caring for women with both hot flashes and mood symptoms should consider other factors affecting psychological function. @MenopauseJrnl
https://t.co/AzMDwcwT9l
0
0
0
So grateful to @SGIM, my mentors, nominators, and collaborators for this award and the opportunity to advance the science of GIM! @DBatesSafety
@AlisonHuangMD
@UCSFDGIM
@j_r_a_m
@Bruce_Landon
@UCSF_DOCIT
🎉 Congratulations to our #SGIM25 Award Winner! 🎉 Please join us in celebrating Lisa Rotenstein, MBA, MD (@LisaRotenstein), recipient of the Outstanding Junior Investigator of the Year Award. Their outstanding work exemplifies excellence in general internal medicine. 👏 Help
5
6
48
Delighted to have collaborated with @MenopauseOrg's @StephFaubionMD and @JAMAInternalMed's Deborah Grady to review the available evidence, including about newer nonhormonal treatment options for vasomotor symptoms, such as neurokinin-3 receptor antagonists.
While hormone therapy is the most effective treatment for vasomotor symptoms, nonhormonal options like SSRIs/SNRIs, gabapentin, and oxybutynin offer modest efficacy.
0
0
5
Grateful for the opportunity to work with such thoughtful and enthusiastic editors, publishers, and staff to advance communication about clinical trials research in the next year.
Celebrating the successful conclusion of another JAMA Week! 🎉 Proud to work alongside this committed team of editors, publishers, staff, board members, & advisors united in the mission of advancing the health of patients & the public through the dissemination of science
1
0
4
Estrogen therapy remains the most effective treatment for menopausal vasomotor symptoms, but our @JAMAInternalMed insights article describes evidence-based non-hormonal treatment options for women who are not candidates for or wish to avoid hormones: https://t.co/GYMWDuog9W
0
4
8
Many have asked where can we watch the new docudrama The Brown Heart…. Here it is: https://t.co/3GaNKD7Q0L Please amplify!
thebrownheart.com
THE BROWN HEART FILM: WATCH HERE
3
7
15
The SPIRIT 2025 statement updates the guidelines for randomized trial protocols to enhance their completeness, transparency, and consistency, benefiting stakeholders involved in clinical research. https://t.co/sfdiwWHJwc
0
8
11
A great loss—one of the very few, and definitely one of the most impactful, large-scale prospective studies conducted by the NIH to improve our understanding and management of aging and chronic disease in women in the U.S.
Every woman, I repeat, every woman of every age, every color, every political affiliation should condemn this, should raise their voice about this, should be terrified about this. Just a few short months ago women’s health advocates were optimistic for the first time in
0
1
3
One group of women receiving little attention in menopause research is South Asians. But as shown by our new @ClimactericIMS report from the @masala_study, women of South Asian ancestry may undergo natural menopause earlier than other women in the USA: https://t.co/Flp4YoNeUQ
1
3
6
Congratulations to @UCSFMedicine's Nancy Yang, awarded a @SocietyGIM 2025 National Young Scholars in GIM Scholarship! Nancy will give an oral research presentation at @SocietyGIM about sexual function in women with urinary incontinence in a multisite trial of pelvic floor yoga.
1
1
5
Postdocs, junior faculty, and researchers new to aging: NIA’s Butler-Williams Scholars Program provides an opportunity to learn about #AgingResearch, #dementia, @NIH #grant writing, and more. Apply by March 31: https://t.co/9QCbuuZyNX
#BWScholars
nia.nih.gov
Learn about the unique opportunities the Butler-Williams Scholars Program provides for junior faculty, researchers who are new to the field of aging, and postdoctoral fellows.
0
12
22
Big News! Our own @DrEnemchukwu is among the winners of the @AmerUrological Young Urologist of the Year! 🏆 We’re thrilled to see her representing @StanfordUrology on this national stage and excited for what’s next! @SWIUorg @StanfordMed
Congratulations to the winners of the @AmerUrological Young Urologist of the Year! 🏆 Special shout-out to our @SWIUorg board member, @DrEnemchukwu - we’re so fortunate to benefit from your passion and leadership! @StanfordUrology
https://t.co/h0W4g6R9St
0
7
39